Abstract: This report describes a unique case involving an obese 16-year-old boy with a mosaic form of trisomy 13 and no previous cardiac history who presented with a new murmur, hypertension, pleural effusions, and congestive heart failure in the context of sore throat and fever. Evaluation revealed a diagnosis of ruptured noncoronary sinus of Valsalva (SOV) aneurysm. The diagnosis and surgical management of a ruptured noncoronary SOV aneurysm in a pediatric patient are briefly outlined. An SOV aneurysm is an … Show more
“…Most of the patients with trisomy 13 die before completing the first year of life and only 5%-10% can survive beyond the first year. In contrast to complete trisomy 13, patients with mosaic trisomy 13 present with fewer and milder anomalies and may survive to late childhood and adulthood [7]. The diagnosis in this case report was made through chromosomal analysis of cultured peripheral blood sample, and it revealed a mosaic result.…”
Trisomy 13 was first described by Patau in 1960. It is a rare genetic disease caused by having an extra copy of chromosome 13. Mosaic trisomy 13 happens when a percentage of the cells are trisomic for chromosome 13, while the remaining cells are euploid. Patau syndrome has a limited survival rate, and most of the carriers die before completing the first year of life. Unlike Patau syndrome, mosaic trisomy 13 is known for longer survival. It is associated with central nervous system malformations, cardiac defects, and psychomotor delay. We report a six-year-old male patient, the third child of a first-degree consanguinity. Born at term via emergency cesarean section due to meconium-stained amniotic fluid and fetal distress. Apgar score nine at one minute and nine at five minutes. Initial examination showed typical dysmorphic features like deepseated eyes, small palpebral fissure, low set of ears, high arched palate, short neck, and right-hand polydactyly. The diagnosis was made through chromosomal analysis, and it revealed mosaic trisomy 13.
“…Most of the patients with trisomy 13 die before completing the first year of life and only 5%-10% can survive beyond the first year. In contrast to complete trisomy 13, patients with mosaic trisomy 13 present with fewer and milder anomalies and may survive to late childhood and adulthood [7]. The diagnosis in this case report was made through chromosomal analysis of cultured peripheral blood sample, and it revealed a mosaic result.…”
Trisomy 13 was first described by Patau in 1960. It is a rare genetic disease caused by having an extra copy of chromosome 13. Mosaic trisomy 13 happens when a percentage of the cells are trisomic for chromosome 13, while the remaining cells are euploid. Patau syndrome has a limited survival rate, and most of the carriers die before completing the first year of life. Unlike Patau syndrome, mosaic trisomy 13 is known for longer survival. It is associated with central nervous system malformations, cardiac defects, and psychomotor delay. We report a six-year-old male patient, the third child of a first-degree consanguinity. Born at term via emergency cesarean section due to meconium-stained amniotic fluid and fetal distress. Apgar score nine at one minute and nine at five minutes. Initial examination showed typical dysmorphic features like deepseated eyes, small palpebral fissure, low set of ears, high arched palate, short neck, and right-hand polydactyly. The diagnosis was made through chromosomal analysis, and it revealed mosaic trisomy 13.
“…Mosaicism was also present in the first reported case of aortic dilatation in trisomy 13 mosaicism. Ghawi et al 7 presented a 16-year-old male patient with trisomy 13 mosaicism with no previous cardiac history who had a new murmur, hypertension, and congestive heart failure. The management included initial stabilization on the night of admission with a diuretic and an antihypertensive agent, along with surgical intervention.…”
Section: Discussionmentioning
confidence: 99%
“…The management included initial stabilization on the night of admission with a diuretic and an antihypertensive agent, along with surgical intervention. 7 …”
“…Ghawi et al reported a patient in adolescence with trisomy 13 and SVA rupture, in whom no cardiac anomalies were found in the neonatal period. SVA is associated with other CHD,16 18 most commonly VSD (44.2%) and aortic regurgitation (43.3%) 16 18 19. Detailed echocardiography is an accurate method for diagnosing SVA 16 20 21.…”
A young adolescent girl with trisomy 13 was admitted twice to the paediatric department: the first time because of haematocolpos due to uterus didelphys and unilateral transverse vaginal septum, and the second time because of heart failure due to ruptured sinus of Valsalva aneurysm. As a consequence of the historical early high mortality rate in trisomy 13, we are not aware of known complications in older patients. With better survival nowadays through childhood, we advise structural ultrasonographic cardiac and female genital screening in trisomy 13 patients reaching adolescent age.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.